These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11042239)

  • 21. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of mild to moderately severe heart insufficiency].
    Kaufmann G
    Schweiz Rundsch Med Prax; 1988 May; 77(19):509-10. PubMed ID: 3387738
    [No Abstract]   [Full Text] [Related]  

  • 23. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.
    van Kraaij DJ; Jansen RW; Gribnau FW; Hoefnagels WH
    Drugs Aging; 2000 Apr; 16(4):289-300. PubMed ID: 10874524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Euro heart failure survey. Medical treatment not in line with current guidelines.
    Drechsler K; Dietz R; Klein H; Wollert KC; Storp D; Molling J; Zeymer U; Niebauer J
    Z Kardiol; 2005 Aug; 94(8):510-5. PubMed ID: 16049652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient management of congestive heart failure.
    Massin EK
    Tex Heart Inst J; 1998; 25(4):238-50. PubMed ID: 9885099
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors for heart failure with reduced ejection fraction or left ventricular dysfunction: A complementary network meta-analyses.
    Guo WQ; Li L
    Int J Cardiol; 2016 Jul; 214():10-2. PubMed ID: 27055158
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
    Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of the prognostic importance of left ventricular systolic function and heart failure after myocardial infarction: 17-year follow-up of the TRACE register.
    Kümler T; Gislason GH; Køber L; Torp-Pedersen C
    Eur J Heart Fail; 2010 Aug; 12(8):805-11. PubMed ID: 20494923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary issues in heart failure.
    Ghali JK
    Am Heart J; 1999 Jul; 138(1 Pt 1):5-8. PubMed ID: 10385753
    [No Abstract]   [Full Text] [Related]  

  • 30. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches.
    J Card Fail; 1999 Dec; 5(4):357-82. PubMed ID: 10634677
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Renal effect of treatment for heart failure].
    Rasmussen ZZ; Barfod T; Klit J
    Ugeskr Laeger; 2009 Feb; 171(9):718. PubMed ID: 19257999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimising heart failure pharmacotherapy: the ideal combination.
    Cleland JG; Dutka DP
    Br Heart J; 1994 Aug; 72(2 Suppl):S73-9. PubMed ID: 7946765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure.
    Konstam MA
    Eur Heart J; 1995 Dec; 16 Suppl N():59-64. PubMed ID: 8682063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
    Gupta S; Waywell C; Gandhi N; Clayton N; Keevil B; Clark AL; Ng LL; Brooks N; Neyses L
    Eur J Heart Fail; 2010 Jul; 12(7):746-52. PubMed ID: 20525705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
    Echemann M; Alla F; Briançon S; Juillière Y; Virion JM; Mertès PM; Villemot JP; Zannad F; Aliot E; Breton Ch; KhalifE K; Neimann JL; Allam S; Admant P; Baille N; Bellanger P; D'Hôtel R; Dambrine P; Dodet JF; Graille M; Kessler M; Rebeix G; Royer ; Saulnier JP; Thisse JY; Trutt B; Vidal P; Vuillemin MCh; Delahaye ; Ducimetière P; Fagnani F; Guize L;
    Eur J Heart Fail; 2002 Oct; 4(5):647-54. PubMed ID: 12413509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.